CHAMPIONS ONCOLOGY, INC.

CSBR

CHAMPIONS ONCOLOGY, INC.

CSBR

Insider Sentiment (TTM):

Last Purchase:2024-01-12Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,698,735Shares Outstanding:13,832,385Institutional Ownership Pct.:41.20%

Earnings Market Reaction:

Filing Date:2026-07-27Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	-	7	9	10	-	3	3	3	-	4	6	5
Cash	5	-	-	-	10	-	-	-	3	-	-	-
Accounts Receivable Net Current	13	12	12	9	11	16	10	9	10	8	8	9
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	1	1	1	1	1
Assets Current	19	20	21	21	22	20	14	13	14	13	14	15
Operating Lease Right Of Use Asset	4	4	4	5	5	5	6	6	6	7	7	7
Property Plant And Equipment And Finance Lease Rig…	4	4	4	4	4	5	5	5	6	7	7	7
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Assets	27	28	30	31	32	31	25	25	26	27	28	30
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	7	6	6	5	4	5	5	5	6	5	5	6
Accrued Liabilities Current	3	3	2	2	3	2	2	2	2	2	2	2
Operating Lease Liability Current	2	2	2	2	1	1	1	1	1	1	1	1
Other Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Contract With Customer Liability Current	9	10	12	14	15	11	10	10	12	13	13	11
Liabilities Current	20	21	22	23	24	20	19	19	22	22	21	20
Operating Lease Liability Noncurrent	3	3	4	4	5	5	5	6	6	6	7	7
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	1
Liabilities	23	24	26	27	29	25	25	25	28	29	28	28
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Common Value	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Additional Paid In Capital Common Stock	86	85	85	85	84	84	84	84	83	83	83	82
Retained Earnings Accumulated Deficit	-81	-80	-80	-80	-80	-78	-83	-83	-85	-84	-82	-80
Stockholders Equity	4	4	4	4	4	5	1	-0	-2	-2	0	2
Minority Interest	0	0	0	0	0	-	-	-	-	-	-	-
Liabilities And Stockholders Equity	27	28	30	31	32	31	25	25	26	27	28	30
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	14	14	14	14	14	14	14	14	14	14	14	14
Shares Outstanding	14	14	14	14	14	14	14	14	14	14	14	13

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-21.20%	-18.80%	-27.23%	-13.08%	-16.03%	-24.74%	0.52%	4.36%	1.74%	-	-	-
2025	-5.15%	-20.79%	-10.50%	51.52%	76.00%	59.04%	-27.68%	-38.72%	-32.12%	-15.87%	-11.87%	-15.61%
2024	17.27%	0.18%	-3.64%	24.69%	22.43%	14.81%	-11.15%	-6.22%	-17.18%	-11.68%	-15.84%	-5.15%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Liquidity Ratios
Current Ratio	0.96	0.98	0.96	0.93	0.94	0.99	0.75	0.69	0.63	0.60	0.67	0.73
Quick Ratio	0.91	0.93	0.91	0.87	0.88	0.96	0.70	0.62	0.56	0.56	0.63	0.68
Working Capital	-703.00K	-492.00K	-809.00K	-1.68M	-1.50M	-173.00K	-4.78M	-5.99M	-7.90M	-8.77M	-6.93M	-5.46M
Leverage & Debt
Debt to Equity	5.63	5.50	6.22	7.70	7.57	4.60	36.06	-76.10	-14.73	-14.02	303.24	14.72
Debt Ratio	0.85	0.85	0.86	0.88	0.88	0.82	0.97	1.01	1.07	1.08	1.00	0.94
Efficiency & Turnover
Asset Turnover TTM	2.00	1.96	2.11	2.05	1.95	2.04	2.00	1.88	1.66	1.56	1.55	1.64
Days Sales Outstanding TTM	74.88	87.71	68.75	59.38	66.44	73.75	61.98	63.52	63.81	59.13	60.88	63.40
Receivables Turnover TTM	4.87	4.16	5.31	6.15	5.49	4.95	5.89	5.75	5.72	6.17	6.00	5.76
Per Share Metrics
Diluted EPS TTM	-0.08	-0.17	0.17	0.21	0.33	0.45	-0.04	-0.24	-0.54	-0.72	-0.71	-0.56
Free Cash Flow Per Share TTM	-0.36	0.27	0.41	0.53	0.51	-0.10	-0.21	-0.15	-0.52	-0.49	-0.35	-0.19
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	48.00%	45.87%	50.11%	48.47%	50.15%	51.58%	44.75%	44.27%	41.38%	40.09%	41.30%	42.75%
Operating Profit Margin TTM	-1.92%	-4.53%	3.68%	4.74%	8.00%	10.73%	-1.47%	-6.73%	-14.67%	-19.51%	-18.98%	-14.28%
Net Profit Margin TTM	-1.98%	-3.99%	4.21%	5.14%	8.26%	10.97%	-1.12%	-6.58%	-14.51%	-19.76%	-19.28%	-14.39%
Growth Metrics
Net Revenue Growth (1Y)	4.36%	-1.10%	9.06%	10.11%	13.54%	19.03%	7.19%	-1.96%	-6.90%	-8.29%	-7.61%	2.10%
Net Income Growth (1Y)	-124.99%	-135.97%	-511.71%	-186.02%	-164.61%	-166.07%	-93.79%	-55.20%	36.38%	211.99%	-9,023.15%	-1,990.77%
EPS Growth (1Y)	-124.68%	-135.49%	-505.79%	-184.80%	-164.08%	-165.55%	-93.84%	-55.48%	36.32%	211.19%	-9,044.03%	-1,992.96%
Valuation Metrics
P/E TTM	-70.16	-43.91	38.32	29.82	20.78	23.43	-88.88	-19.17	-9.03	-8.12	-7.65	-11.58
P/B TTM	20.27	23.19	22.62	24.84	25.89	27.53	78.05	-196.13	-34.53	-38.38	792.41	46.13
P/S TTM	1.39	1.75	1.61	1.53	1.72	2.57	0.99	1.26	1.31	1.60	1.47	1.67
Market Cap	82.44M	101.51M	94.34M	87.14M	97.67M	150.57M	53.15M	65.11M	65.71M	78.98M	73.69M	87.79M
Enterprise Value	77.57M	94.39M	85.82M	76.82M	96.73M	147.37M	50.40M	62.22M	63.09M	74.51M	68.18M	82.93M
Calculated Values
Free Cash Flow TTM	-5.04M	3.82M	5.64M	7.24M	7.00M	-1.44M	-2.90M	-2.01M	-6.98M	-6.61M	-4.78M	-2.61M
Net Debt	-4.87M	-7.13M	-8.52M	-10.33M	-937.00K	-3.20M	-2.75M	-2.89M	-2.62M	-4.47M	-5.51M	-4.87M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-01-12Purchase

Owner: Mendelson, Daniel Newman

Title: -

Shares: 1,000

Price/Share: $6.50

Value: $6,500.00

Shares Owned: 198,625

Relationship: Director

Ownership: Direct

2024-01-11Purchase

Owner: Mendelson, Daniel Newman

Title: -

Shares: 2,000

Price/Share: $6.27

Value: $12,540.00

Shares Owned: 197,625

Relationship: Director

Ownership: Direct

2024-01-10Purchase

Owner: Mendelson, Daniel Newman

Title: -

Shares: 2,944

Price/Share: $6.31

Value: $18,576.64

Shares Owned: 195,625

Relationship: Director

Ownership: Direct

2024-01-09Purchase

Owner: Mendelson, Daniel Newman

Title: -

Shares: 3,000

Price/Share: $6.25

Value: $18,750.00

Shares Owned: 192,681

Relationship: Director

Ownership: Direct

2024-01-08Purchase

Owner: Mendelson, Daniel Newman

Title: -

Shares: 1,000

Price/Share: $6.15

Value: $6,150.00

Shares Owned: 189,681

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-01-12	Mendelson, Daniel Newman	Director	-	Direct	Purchase	1,000	6.50	$6,500.00	198,625	4
2024-01-11	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,000	6.27	$12,540.00	197,625	4
2024-01-10	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,944	6.31	$18,576.64	195,625	4
2024-01-09	Mendelson, Daniel Newman	Director	-	Direct	Purchase	3,000	6.25	$18,750.00	192,681	4
2024-01-08	Mendelson, Daniel Newman	Director	-	Direct	Purchase	1,000	6.15	$6,150.00	189,681	4
2024-01-05	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,000	6.09	$12,180.00	188,681	4
2024-01-04	Mendelson, Daniel Newman	Director	-	Direct	Purchase	3,000	6.12	$18,360.00	186,681	4
2024-01-03	Mendelson, Daniel Newman	Director	-	Direct	Purchase	500	5.83	$2,915.00	183,681	4
2023-12-21	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,500	4.92	$12,300.00	183,181	4
2023-12-20	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,100	4.82	$10,122.00	180,681	4
2023-12-19	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	4.75	$23,750.00	178,581	4
2023-10-11	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	6.40	$32,000.00	163,081	4
2023-10-10	Mendelson, Daniel Newman	Director	-	Direct	Purchase	1,100	6.41	$7,051.00	158,081	4
2023-10-06	Mendelson, Daniel Newman	Director	-	Direct	Purchase	1,530	6.48	$9,914.40	156,981	4
2023-10-05	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,000	6.47	$12,940.00	155,451	4
2023-10-04	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	6.40	$32,000.00	153,451	4
2023-10-03	Mendelson, Daniel Newman	Director	-	Direct	Purchase	2,500	6.30	$15,750.00	148,451	4
2023-09-29	Mendelson, Daniel Newman	Director	-	Direct	Purchase	4,000	6.16	$24,640.00	173,581	4
2023-09-28	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	6.22	$31,100.00	169,581	4
2023-09-27	Mendelson, Daniel Newman	Director	-	Direct	Purchase	1,500	5.95	$8,925.00	164,581	4
2023-09-26	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	5.65	$28,250.00	145,951	4
2023-09-22	Mendelson, Daniel Newman	Director	-	Direct	Purchase	3,812	5.50	$20,966.00	140,951	4
2023-09-21	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	5.51	$27,550.00	137,139	4
2023-09-20	Mendelson, Daniel Newman	Director	-	Direct	Purchase	4,018	5.51	$22,139.18	132,139	4
2023-09-19	Mendelson, Daniel Newman	Director	-	Direct	Purchase	5,000	5.28	$26,400.00	128,121	4
2023-03-17	Morris, Ronnie	Director,Officer	CEO	Direct	Purchase	12,382	4.04	$50,023.28	858,878	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

41.20%

Inst. Shares: 5,698,735

Shares Outstanding: 13,832,385

2025-12-31

40.96%

Inst. Shares: 5,687,511

Shares Outstanding: 13,886,797

2025-09-30

40.63%

Inst. Shares: 5,604,266

Shares Outstanding: 13,791,913

2025-06-30

41.43%

Inst. Shares: 5,712,692

Shares Outstanding: 13,788,414

2025-03-31

42.94%

Inst. Shares: 5,865,609

Shares Outstanding: 13,659,786

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,698,735	13,832,385	41.20%
2025-12-31	5,687,511	13,886,797	40.96%
2025-09-30	5,604,266	13,791,913	40.63%
2025-06-30	5,712,692	13,788,414	41.43%
2025-03-31	5,865,609	13,659,786	42.94%
2024-12-31	5,664,777	13,700,627	41.35%
2024-09-30	5,740,705	13,593,766	42.23%
2024-06-30	5,716,250	13,593,766	42.05%
2024-03-31	5,452,098	13,547,604	40.24%
2023-12-31	5,456,948	13,593,758	40.14%
2023-09-30	5,580,475	13,497,061	41.35%
2023-06-30	5,655,407	13,506,782	41.87%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

CHAMPIONS ONCOLOGY, INC. (CSBR) — SEC Financial Statements & Analysis

CHAMPIONS ONCOLOGY, INC. (CSBR) is a biological products, (no diagnostic substances) company, incorporated in DE. CHAMPIONS ONCOLOGY, INC. trades on Nasdaq as: CSBR. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), CHAMPIONS ONCOLOGY, INC. reported a 4.36% year-over-year revenue growth, a Gross Profit Margin of 48.00% (TTM), a Debt-to-Equity ratio of 5.63x, a Price-to-Sales (P/S) ratio of 1.39x (TTM), a Price-to-Book (P/B) ratio of 20.27x (TTM), at a market cap of $82.44M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 4.36%
Gross Profit Margin TTM: 48.00%
Debt To Equity: 5.63x
P/S TTM: 1.39x
P/B TTM: 20.27x
Market Cap: $82.44M

Data as of 2026-04-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CHAMPIONS ONCOLOGY, INC. in?

CHAMPIONS ONCOLOGY, INC. (CSBR) operates in the Biological Products, (No Diagnostic Substances) industry.

What is CSBR's market cap?

CHAMPIONS ONCOLOGY, INC. (CSBR) has a market capitalization of $82.44M as of 2026-04-30.

What exchange does CSBR trade on?

CHAMPIONS ONCOLOGY, INC. (CSBR) trades on the Nasdaq.

Where is CHAMPIONS ONCOLOGY, INC. incorporated?

CHAMPIONS ONCOLOGY, INC. is incorporated in DE.